Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1235, 2000-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Basiliximab may be beneficial for treatment-refractory chronic atopic dermatitis
Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. :
Treatment-refractory acute rejection of intestinal transplants may respond to infliximab
Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. :
Cyclosporin `may be a therapeutic option' in patients with refractory coeliac disease
Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. :